Facebook Pixel Code

Fredun Pharmaceuticals Share Price

NSE
BSE

FREDUN PHARMACEUTICALS

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Fredun Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹1,229.00 Closed
1.01₹ 12.25
As on Sep 23, 2025, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Fredun Pharmaceuticals Price Performance

Today's LowToday's High
₹1,190.05₹1,244.95
₹1,229.00
52 Weeks' Low52 Weeks' High
₹635.00₹1,340.00
₹1,229.00
Open Price
₹1,216.75
Prev. Close
₹1,216.75
Volume
6,965

Over the last 5 years, the share price of Fredun Pharmaceuticals has gained 39.95% CAGR. Over the past year, the corresponding return has been 58.62%.

Fredun Pharmaceuticals’s current P/E of 24.75x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Fredun Pharmaceuticals Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Fredun Pharmaceuticals
-1.55-2.9850.0074.5558.625.7539.95
Sun Pharmaceutical Industries
1.26-1.54-1.84-8.63-12.4221.0026.54
Divi's Laboratories
-0.95-3.36-8.982.1512.3618.3513.97
Torrent Pharmaceuticals
3.67-0.2115.7412.385.9834.2122.46
Cipla
-1.95-4.571.970.23-7.8312.6914.78
Dr. Reddy's Laboratories
-0.191.83-0.738.11-1.6416.475.10
Mankind Pharma
-0.360.1011.337.91-3.4421.5912.45
Zydus Lifesciences
1.002.159.7012.82-0.9143.1322.18
Lupin
-2.371.943.86-5.60-8.2245.6314.54
Alkem Laboratories
1.072.7916.8510.16-6.9119.5415.21
Aurobindo Pharma
1.573.910.85-8.30-25.0728.937.27
Abbott India
-2.31-4.05-2.69-2.656.7919.2213.60
Glenmark Pharmaceuticals
-2.833.2019.7035.1817.9373.8133.80
Laurus Labs
1.724.3036.6046.0691.9221.2727.22
Biocon
00.042.273.08-2.788.22-3.20
GlaxoSmithKline Pharmaceuticals
0.72-1.46-12.97-4.321.2625.2411.64
Anthem Biosciences
-1.17-2.6012.4212.4212.423.982.37
Ipca Laboratories
5.91-0.933.49-4.52-4.7516.655.37
Cohance Lifesciences
-9.040.09-8.26-23.33-27.9527.2919.61
Gland Pharma
-0.373.7115.4924.919.12-2.132.04

Over the last one year, Fredun Pharmaceuticals has gained 58.62% compared to peers like Sun Pharmaceutical Industries (-12.42%), Divi's Laboratories (12.36%), Torrent Pharmaceuticals (5.98%). From a 5 year perspective, Fredun Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (26.54%) and Divi's Laboratories (13.97%).

Fredun Pharmaceuticals Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Fredun Pharmaceuticals Stock Technicals

Moving Average

DaySMAEMA
51,235.011,237.25
101,247.591,235.76
201,232.431,209.08
501,087.011,102.09
100922.97984.19
200812.89887.86

Fredun Pharmaceuticals Share Holding Pattern

In the latest quarter, Fredun Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 1.59%, FII holding unchanged at 0.00%, and public shareholding moved up to 49.49% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Fredun Pharmaceuticals Corporate Actions

Date Time
Announcement
Sep 22, 2025, 6:08 AM ISTFredun Pharma - Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The Securities And Exchange Board Of Ind
Sep 09, 2025, 12:40 AM ISTFredun Pharma - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201
Sep 09, 2025, 12:33 AM ISTFredun Pharma - Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2024-25
Sep 09, 2025, 12:30 AM ISTFredun Pharma - Notice Of Book Closure For The Purpose Of 38Th Annual General Meeting (AGM)
Sep 09, 2025, 12:27 AM ISTFredun Pharma - Submission Of The 38Th Annual Report Of Fredun Pharmaceuticals Limited For The Financial Year 2024-25.

About Fredun Pharmaceuticals

Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 451.71 Cr. and Equity Capital is Rs. 4.72 Cr. for the Year ended 31/03/2025.

Management

  • Dr.(Mrs.) Daulat N Medhora
    Chairman & Jt. M. D
  • Mr. Fredun Medhora
    Managing Director & CFO
  • Mr. Nariman Medhora
    Non Executive Director
  • Dr. Rohinton Kanga
    Ind. Non-Executive Director
  • Dr. Aspi Raimalwala
    Ind. Non-Executive Director
  • Mrs. Daisy D�souza
    Ind. Non-Executive Director

FAQs on Fredun Pharmaceuticals Share Price

What is the share price of Fredun Pharmaceuticals?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Fredun Pharmaceuticals is ₹1,229.00 as on Sep 23, 2025.

What kind of stock is Fredun Pharmaceuticals?

The Fredun Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Fredun Pharmaceuticals?

The market cap of Fredun Pharmaceuticals is ₹580.29 Cr as on Sep 23, 2025.

What are today's High and Low prices of Fredun Pharmaceuticals?

Today’s highest and lowest price of Fredun Pharmaceuticals are ₹1,244.95 and ₹1,190.05.

What are the 52 Week High and 52 Week Low of Fredun Pharmaceuticals?

The 52-week high/low is the highest and lowest price at which Fredun Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Fredun Pharmaceuticals is ₹1,340.00 and 52-week low of Fredun Pharmaceuticals is ₹635.00 as on Sep 23, 2025.

How has the Fredun Pharmaceuticals performed historically in terms of returns?

The Fredun Pharmaceuticals has shown returns of 1.01% over the past day, -2.98% for the past month, 50.0% over 3 months, 58.62% over 1 year, 5.75% across 3 years, and 39.95% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Fredun Pharmaceuticals?

P/E ratio of and PB ratio of Fredun Pharmaceuticals are 24.75 and 4.43 on Sep 23, 2025. While the company gives a dividend yield of 0.06 per annum.

icon
Market Data